Basic Information
ID: ALA5117301
Type: Functional
Description: Antiviral activity against SARS-Cov2 USA-WA1/2020 infected in African green monkey Vero E6 cells assessed as viral plaque reduction measured after 3 days by plaque reduction neutralization test
Format: BAO_0000218
Organism: Severe acute respiratory syndrome coronavirus 2
Strain: USA-WA1/2020
Cell type: Vero E6
Target: SARS-CoV-2(ALA4303835)
Document: ALA5113464
Antiviral activity against SARS-Cov2 USA-WA1/2020 infected in African green monkey Vero E6 cells assessed as viral plaque reduction measured after 3 days by plaque reduction neutralization test: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA5117301
EC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 600.76 | 3.15 | 3.15 |
| 595.14 | 2.88 | 2.88 |
| 558.68 | 1.98 | 1.98 |
| 577.12 | 3.26 | 3.26 |
| 574.72 | 2.62 | 2.62 |
| 635.20 | 3.80 | 3.80 |
| 530.67 | 2.46 | 2.46 |